Literature DB >> 1991434

Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography.

R Gregory1, S Edwards, N A Yateman.   

Abstract

OBJECTIVE: To assess the importance of temperature, light, agitation, and regular withdrawal of insulin on the rates of appearance of three groups of insulin transformation products (ITPs) in vials of human and beef soluble insulin. RESEARCH DESIGN AND METHODS: Twelve insulin-treated patients (6 receiving human soluble insulin, 6 receiving beef soluble insulin) participated in the study. Reverse-phase high-performance liquid chromatography was used to measure ITP in serial samples from vials stored in various laboratory environments or issued to patients. Vials in the laboratory were analyzed on nine occasions over 26 wk; those issued to patients were analyzed weekly.
RESULTS: Results were expressed as rates of change (% total protein/wk). Except for human insulin stored at 4 degrees C, sampling did not accelerate transformation. Storage at higher temperatures caused more rapid transformation to all ITP groups, and human insulin was more susceptible than beef insulin. Exposure to light accelerated transformation mainly to group 3 ITP. Fibrillation occurred in beef but not human insulin carried in a shirt pocket. Results from patients' vials were consistent with reported storage conditions.
CONCLUSIONS: All three ITP groups form in human and beef soluble insulin. Their rate of production is a function of temperature and light exposure. Differences between the two insulins were probably due to differences in formulation. Patients should be discouraged from hoarding vials and storing insulin in direct sunlight. One or more ITPs could contribute to the residual immunogenicity of modern insulin preparations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991434     DOI: 10.2337/diacare.14.1.42

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

1.  Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein.

Authors:  Yang Liu; Juneyoung Lee; Kathryn M Mansfield; Jeong Hoon Ko; Sahar Sallam; Chrys Wesdemiotis; Heather D Maynard
Journal:  Bioconjug Chem       Date:  2017-01-03       Impact factor: 4.774

2.  Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

Authors:  J Brange; L Langkjaer; S Havelund; A Vølund
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

3.  Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics.

Authors:  Congzhou Wang; Gail Sudlow; Zheyu Wang; Sisi Cao; Qisheng Jiang; Alicia Neiner; Jeremiah J Morrissey; Evan D Kharasch; Samuel Achilefu; Srikanth Singamaneni
Journal:  Adv Healthc Mater       Date:  2018-10-19       Impact factor: 9.933

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.